Daily Research News Online

Happy Easter from Hasson Associates! Call us on 020 7637 1300

Most viewed items
in the last week...

  1.   Vision Critical Expands in London  
  2.   Ipsos Sells Motion Picture Group  
  3.   GfK Hires Sampling Expert  
  4.   WorldOne Secures $35m for Physician Community  
  5.   Four New Markets for Nielsen Online Ratings  
  6.   GfK Integrates and Renames Blue Moon Division  
Each ( * ) indicates > 1,000 views
Select a region below...
  • UK
  • USA
  • Asia
  • Australia
MrWeb UK
MrWeb USA
MrWeb Asia
MrWeb Australia

Phorm Continues 'Long Wait for Revenues'

July 2 2012
Behavioural ad targeting company Phorm has reported another large operating loss, with revenues for 2011 not taking off as expected, but says it believes that ‘it will become increasingly clear to investors that the long wait for revenues will have been worthwhile.’

Kent ErtugrulNine months ago Phorm had cumulative losses to date of an alarming $150.9 million, and reported that it was continuing to burn cash at the rate of more than $2m a month. However it also said it had seen promising results from operations in Brazil and early trials in Romania, and Chairman and CEO Kent Ertugrul (pictured) spoke of ‘near term profitability’ for the Romanian operation.

The company now says that although it did start generating revenue in 2011, revenues - a mere $50k - were ‘significantly lower than original expectations’ with slow growth due largely to ‘changes to and challenges within the ISP networks in Brazil.’ Operating losses for the year were $30.5m - versus $27.9m in 2010, although excluding non-cash items the figure fell, from $26.0m in 2010 to $24.2m last year.

The company says proceeds from its equity fundraising in the Q4 2011 allowed it to repay all loan notes in full, making it ‘debt-free’. It also reports a conditional agreement with China City Investments Limited for a £20m equity investment into Phorm China, valuing the latter alone at £100m (post money) - completion is expected at the end of this month.

Erturgrul says the company needs further funds given ‘current uncertainty with respect to the scale and speed of the revenues arising from the current deployment’ but is ‘actively engaged in further funding discussions’. He adds in conclusion: ‘we expect significant additional news flow during the second half of this year and believe that it will become increasingly clear to investors that the long wait for revenues will have been worthwhile.’

Web site: www.phorm.com .